A 12-week, multicenter study to evaluate the efficacy and safety of orally administered valsartan/amlodipine combo based therapy vs amlodipine monotherapy in black patients with stage II hypertension.

Trial Profile

A 12-week, multicenter study to evaluate the efficacy and safety of orally administered valsartan/amlodipine combo based therapy vs amlodipine monotherapy in black patients with stage II hypertension.

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Nov 2011

At a glance

  • Drugs Amlodipine/valsartan (Primary) ; Amlodipine
  • Indications Hypertension
  • Focus Pharmacodynamics; Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 07 Nov 2011 Actual end date (Apr 2007) added as reported by ClinicalTrials.gov.
    • 04 Jun 2007 Status changed from in progress to completed.
    • 10 Jul 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top